[ET Net News Agency, 27 February 2024] Morgan Stanley lowered the target price for
Joinn (06127) to HKD11.5 from HKD26.28 and downgraded the rating to "equal-weight" from
"overweight".
The research house said performance pressure may persist into 2024 due to ongoing soft
domestic biotech funding and unclear reopening timetable of non-human primate (NHP)
exports. (RC)